SCHEMBL14293441

SCHEMBL14293441

COc1cc(O)ccc1-c1nnc(S)n1-c1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.43
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
TP53 P04637 1/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 3/20 0.39
NPC1 O15118 2/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ESR1 P03372 2/20 0.38
NOTUM Q6P988 1/20 0.38
TSHR P16473 3/20 0.38
ALOX15 P16050 1/20 0.38
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL930093 0.86 ESR1 (0.48) ALDH1A1HPGDKMT2AMAPTMEN1
SCHEMBL931338 0.79 GAA (0.43) ALDH1A1KDM4ESMN1; SMN2KMT2AMAPT
SCHEMBL6408096 0.78 PRKCZ (0.43) ALDH1A1TP53KMT2AMAPTMEN1
SCHEMBL931683 0.74 NOTUM (0.39) KMT2AMEN1NPC1POLBRAB9A
SCHEMBL4933212 0.73 ESR1 (0.50) ALDH1A1HPGDKMT2AMAPTMEN1
SCHEMBL930860 0.72 GAA (0.42) ALDH1A1KDM4ETP53KMT2AMAPT
SCHEMBL931653 0.71 GAA (0.45) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL929867 0.71 PRKCZ (0.43) KMT2AMAPTMEN1MAPK1NOTUM
SCHEMBL932183 0.71 GAA (0.40) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL932177 0.71 ESR1 (0.48) ALDH1A1KDM4EHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021364-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2008-02-21 WO disclosed